InvestorsHub Logo
Followers 3
Posts 219
Boards Moderated 0
Alias Born 11/06/2016

Re: GAB post# 2878

Friday, 01/18/2019 12:04:00 AM

Friday, January 18, 2019 12:04:00 AM

Post# of 3073
It's the opposite: Elysium is trying to avoid paying royalties or infringement damages after Elysium stopped licensing ChromaDex's patents and instead produced its own competing (and apparently infringing) version.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News